This study was designed to evaluate the impact of transjugular intrahepatic portosystemic shunts (TIPS) on liver transplantation. Historically, the complications of portal hypertension have been temporized with sclerotherapy or surgical portosystemic shunts. In patients whose liver disease progresse
Impact of transjugular intrahepatic portosystemic shunt on orthotopic liver transplantation
โ Scribed by Fabrice Menegaux; Edward Baker; Emmet B. Keeffe; Humberto Monge; Hiroto Egawa; Carlos O. Esquivel
- Publisher
- Springer
- Year
- 1994
- Tongue
- English
- Weight
- 655 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0364-2313
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Background: Transjugular intrahepatic portosystemic shunts (TIPS) have been used to control symptomatic portal hypertension in patients awaiting liver transplant. Although their role in pretransplantation patients is well established, their role in posttransplantation patients is unclear. Study Desi
A 44-year-old man with a history of cirrhosis secondary to hepatitis C, status post orthotopic liver transplantation in 2001, with recurrent graft cirrhosis and end-stage renal disease on hemodialysis (Model for End-Stage Liver Disease 29) presented with massive variceal hemorrhage. Despite endoscop
Hepatic hydrothorax is a relatively infrequent but potentially serious complication of cirrhosis resulting from the accumulation of ascitic fluid in the chest cavity. Medical management is initially directed at controlling ascites formation, but invasive therapeutic procedures may be required if sym